{"id":41470,"date":"2026-08-27T02:08:04","date_gmt":"2026-08-27T02:08:04","guid":{"rendered":"https:\/\/g-medtech.com\/news\/?p=41470"},"modified":"2026-08-27T02:13:31","modified_gmt":"2026-08-27T02:13:31","slug":"philips-awarded-arpa-h-grant-to-advance-ai-enabled-robotic-stroke-care","status":"publish","type":"post","link":"https:\/\/g-medtech.com\/news\/ru\/philips-awarded-arpa-h-grant-to-advance-ai-enabled-robotic-stroke-care\/","title":{"rendered":"Philips Awarded ARPA-H Grant to Advance AI-Enabled Robotic Stroke Care"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><a href=\"https:\/\/g-medtech.com\/directory\/listings\/royal-philips\/\" target=\"_blank\" rel=\"noreferrer noopener\">Royal Philips<\/a> has received an award of up to $33.7 million under the Advanced Research Projects Agency for Health (ARPA-H, an agency within the U.S. Department of Health and Human Services (HHS)) Autonomous Interventions and Robotics program to advance AI-enabled robotic procedure automation for stroke care. Working with Johns Hopkins University, Boston University, and Dr. J Mocco of Weill Cornell Medicine, Philips will develop technologies for remote-assisted and increasingly automated endovascular procedures, helping expand access to advanced stroke care.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Access to timely stroke treatment remains one of healthcare&#8217;s greatest challenges. In the United States, approximately 335,000 patients each year are eligible for thrombectomy, a minimally invasive procedure that can reverse the effects of a stroke and prevent long-term disability when performed early. Yet only around 12% of eligible patients receive the treatment, while more than half of Americans live over an hour from a hospital capable of performing it. Globally, fewer than 3% of eligible patients with large-vessel occlusion receive mechanical thrombectomy, despite stroke remaining the world&#8217;s second leading cause of death.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Philips is advancing robotic procedure automation by integrating imaging, robotics, AI-enabled automation, and smart interventional devices on its Azurion image-guided therapy platform. The project will develop technologies for endovascular navigation, robotic device control, image-based procedural guidance, workflow automation, and remote intervention. These technologies are designed to support image-guided procedures while enabling increasing levels of supervised autonomy under expert clinical oversight.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bert van Meurs, Chief Business Leader of Image-Guided Therapy at Philips, said the ARPA-H program accelerates the company&#8217;s long-term vision for image-guided intervention. Van Meurs noted that Philips is helping shape a future where expert care is no longer limited by geography or workforce constraints, and that the goal is not to replace expertise but to make it scalable and accessible.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Betsabeh Madani-Hermann, Head of Research at Philips, said strong robotics and AI research has laid the scientific foundation for this effort, building on years of foundational work in image-guided and robotics procedural automation to help expand access to time-critical stroke intervention.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Johns Hopkins University will be responsible for developing autonomous device navigation, led by Axel Krieger, PhD, Associate Professor in Mechanical Engineering. Boston University will be responsible for developing steerable catheters, co-led by Tommaso Ranzani, PhD, and Sheila Russo, PhD. Dr. J Mocco, Chair of Neurological Surgery at Weill Cornell Medicine and an additional clinical collaborator, said robotics has the potential to improve precision and accuracy in endovascular stroke care while also extending specialist expertise through remote procedures. Mocco added that he is excited to work alongside Philips and the academic partners in this program to translate this potential into clinically meaningful innovation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Philips has more than 20,000 image-guided therapy systems installed across more than 80 countries, with a patient treated using a Philips image-guided therapy system every second. The ARPA-H AIR program represents the next step in advancing Philips&#8217; vision to help make expert endovascular care available to more patients through innovative image-guided therapies. The technologies described are under development, with future clinical use or commercial availability subject to applicable regulatory requirements.<\/p>","protected":false},"excerpt":{"rendered":"<p>Philips has received an up to $33.7 million award from ARPA-H to develop AI-enabled robotic procedure automation for stroke care, working with Johns Hopkins University and Boston University to expand access to specialized endovascular interventions.<\/p>","protected":false},"author":2,"featured_media":41471,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"colormag_page_layout":"default_layout","footnotes":""},"categories":[7,681,10],"tags":[57,758],"class_list":["post-41470","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-americas","category-care-therapy","category-strategic-development","tag-philips","tag-robotics"],"_links":{"self":[{"href":"https:\/\/g-medtech.com\/news\/ru\/wp-json\/wp\/v2\/posts\/41470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/g-medtech.com\/news\/ru\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/g-medtech.com\/news\/ru\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/ru\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/ru\/wp-json\/wp\/v2\/comments?post=41470"}],"version-history":[{"count":2,"href":"https:\/\/g-medtech.com\/news\/ru\/wp-json\/wp\/v2\/posts\/41470\/revisions"}],"predecessor-version":[{"id":41473,"href":"https:\/\/g-medtech.com\/news\/ru\/wp-json\/wp\/v2\/posts\/41470\/revisions\/41473"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/ru\/wp-json\/wp\/v2\/media\/41471"}],"wp:attachment":[{"href":"https:\/\/g-medtech.com\/news\/ru\/wp-json\/wp\/v2\/media?parent=41470"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/ru\/wp-json\/wp\/v2\/categories?post=41470"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/ru\/wp-json\/wp\/v2\/tags?post=41470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}